
Pharmaceutical bosses have said research and development (R&D) in the UK sector risks “losing out to other countries” as US giant Merck scrapped plans for a £1 billion London centre in a major blow to the industry.
Merck, known as MSD in the UK and Europe, is moving its life sciences operation to the US in a move that will impact around 125 British jobs.